These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16110059)
21. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada. Desjardins JG CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417 [TBL] [Abstract][Full Text] [Related]
23. Hospital companies say ads create understanding of industry's role. Rev Fed Am Hosp; 1977 Jun; 10(3):34-5, 38. PubMed ID: 10242908 [No Abstract] [Full Text] [Related]
24. Pharmaceutical industry sets new guidelines for marketing to physicians. Psychiatr Serv; 2002 Aug; 53(8):1043. PubMed ID: 12180431 [No Abstract] [Full Text] [Related]
25. Drug advertising. Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920 [No Abstract] [Full Text] [Related]
26. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines? Lexchin J CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415 [TBL] [Abstract][Full Text] [Related]
27. Letter: Assessment of advertising. Wigle WW Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144 [No Abstract] [Full Text] [Related]
28. Voluntary self-regulatory codes: what should we expect? Lexchin J Am J Bioeth; 2003; 3(3):49-50. PubMed ID: 14594491 [No Abstract] [Full Text] [Related]
29. Sin of omission? Pharmaceutical trade group failed to disclose that ad subject was employee. Becker C Mod Healthc; 2001 Aug; 31(32):5, 8. PubMed ID: 11507868 [No Abstract] [Full Text] [Related]
30. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint. Legler UF Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261 [TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical advertising: from prospectus to marketing. Cambronero-Saiz B J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300 [No Abstract] [Full Text] [Related]
32. Drug promotion: stealth, wealth, and safety. Lancet; 1993 Jun; 341(8859):1507-8. PubMed ID: 8099382 [No Abstract] [Full Text] [Related]
40. FDA tells drug and device makers to give balanced picture of risks in ads, labels. Kuehn BM JAMA; 2009 Jun; 301(24):2541. PubMed ID: 19549965 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]